These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 22011581)

  • 1. Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression.
    Gao Q; Steine EJ; Barrasa MI; Hockemeyer D; Pawlak M; Fu D; Reddy S; Bell GW; Jaenisch R
    Proc Natl Acad Sci U S A; 2011 Nov; 108(44):18061-6. PubMed ID: 22011581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a.
    Liu WB; Cui ZH; Ao L; Zhou ZY; Zhou YH; Yuan XY; Xiang YL; Liu JY; Cao J
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):70-8. PubMed ID: 21163286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.
    Okano M; Bell DW; Haber DA; Li E
    Cell; 1999 Oct; 99(3):247-57. PubMed ID: 10555141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intestinal tumor formation by deletion of the DNA methyltransferase 3a.
    Weis B; Schmidt J; Maamar H; Raj A; Lin H; Tóth C; Riedmann K; Raddatz G; Seitz HK; Ho AD; Lyko F; Linhart HG
    Oncogene; 2015 Apr; 34(14):1822-30. PubMed ID: 24837369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming.
    Na F; Pan X; Chen J; Chen X; Wang M; Chi P; You L; Zhang L; Zhong A; Zhao L; Dai S; Zhang M; Wang Y; Wang B; Zheng J; Wang Y; Xu J; Wang J; Wu B; Chen M; Liu H; Xue J; Huang M; Gong Y; Zhu J; Zhou L; Zhang Y; Yu M; Tian P; Fan M; Lu Z; Xue Z; Zhao Y; Yang H; Zhao C; Wang Y; Han J; Yang S; Xie D; Chen L; Zhong Q; Zeng M; Lowe SW; Lu Y; Liu Y; Wei Y; Chen C
    Nat Cancer; 2022 Jun; 3(6):753-767. PubMed ID: 35449309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation.
    Yan F; Shen N; Pang J; Xie D; Deng B; Molina JR; Yang P; Liu S
    Cell Death Dis; 2014 Sep; 5(9):e1413. PubMed ID: 25210796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analyses of DNA methyltransferase genes in mouse model system.
    Okano M; Li E
    J Nutr; 2002 Aug; 132(8 Suppl):2462S-2465S. PubMed ID: 12163712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
    He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
    Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Guan Y; Liu H; Ma Z; Li SY; Park J; Sheng X; Susztak K
    J Am Soc Nephrol; 2020 Apr; 31(4):765-782. PubMed ID: 32127410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting.
    Kaneda M; Okano M; Hata K; Sado T; Tsujimoto N; Li E; Sasaki H
    Nature; 2004 Jun; 429(6994):900-3. PubMed ID: 15215868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dnmt3a is essential for hematopoietic stem cell differentiation.
    Challen GA; Sun D; Jeong M; Luo M; Jelinek J; Berg JS; Bock C; Vasanthakumar A; Gu H; Xi Y; Liang S; Lu Y; Darlington GJ; Meissner A; Issa JP; Godley LA; Li W; Goodell MA
    Nat Genet; 2011 Dec; 44(1):23-31. PubMed ID: 22138693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of distinct loci for de novo DNA methylation by DNMT3A and DNMT3B during mammalian development.
    Yagi M; Kabata M; Tanaka A; Ukai T; Ohta S; Nakabayashi K; Shimizu M; Hata K; Meissner A; Yamamoto T; Yamada Y
    Nat Commun; 2020 Jun; 11(1):3199. PubMed ID: 32581223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo DNA methyltransferases DNMT3A and DNMT3B are essential for XIST silencing for erosion of dosage compensation in pluripotent stem cells.
    Fukuda A; Hazelbaker DZ; Motosugi N; Hao J; Limone F; Beccard A; Mazzucato P; Messana A; Okada C; San Juan IG; Qian M; Umezawa A; Akutsu H; Barrett LE; Eggan K
    Stem Cell Reports; 2021 Sep; 16(9):2138-2148. PubMed ID: 34416176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dnmt3a protects active chromosome domains against cancer-associated hypomethylation.
    Raddatz G; Gao Q; Bender S; Jaenisch R; Lyko F
    PLoS Genet; 2012; 8(12):e1003146. PubMed ID: 23284304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas.
    Rajendran G; Shanmuganandam K; Bendre A; Muzumdar D; Goel A; Shiras A
    J Neurooncol; 2011 Sep; 104(2):483-94. PubMed ID: 21229291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
    Teneng I; Tellez CS; Picchi MA; Klinge DM; Yingling CM; Snider AM; Liu Y; Belinsky SA
    Oncogene; 2015 Jan; 34(5):621-30. PubMed ID: 24469050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.
    Gray KS; Forrest JC; Speck SH
    J Virol; 2010 May; 84(10):4946-59. PubMed ID: 20200245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression.
    Wang YA; Kamarova Y; Shen KC; Jiang Z; Hahn MJ; Wang Y; Brooks SC
    Cancer Biol Ther; 2005 Oct; 4(10):1138-43. PubMed ID: 16131836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT3L facilitates DNA methylation partly by maintaining DNMT3A stability in mouse embryonic stem cells.
    Veland N; Lu Y; Hardikar S; Gaddis S; Zeng Y; Liu B; Estecio MR; Takata Y; Lin K; Tomida MW; Shen J; Saha D; Gowher H; Zhao H; Chen T
    Nucleic Acids Res; 2019 Jan; 47(1):152-167. PubMed ID: 30321403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG sites preferentially methylated by Dnmt3a in vivo.
    Oka M; Rodić N; Graddy J; Chang LJ; Terada N
    J Biol Chem; 2006 Apr; 281(15):9901-8. PubMed ID: 16439359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.